𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The high specific activity tritium labeling of the ganglion-blocking nicotinic antagonist chlorisondamine

✍ Scribed by Josef Zezula; Hay-Yan J. Wang; Amina S. Woods; Roy A. Wise; Arthur E. Jacobson; Kenner C. Rice


Publisher
John Wiley and Sons
Year
2006
Tongue
French
Weight
111 KB
Volume
49
Category
Article
ISSN
0022-2135

No coin nor oath required. For personal study only.

✦ Synopsis


Chlorisondamine is a bisquaternary ganglion-blocking nicotinic antagonist that accumulates in dopaminergic, serotonergic, and noradrenergic cell bodies; the mechanism of uptake and time-course of retrograde transport are not known. Chlorisondamine could possibly be taken into monoaminergic neurons when blocked nicotinic receptors on those cells are internalized. In order to more easily study the mechanism of the capture and recycling of chlorisondamine, a ligand is needed that has high specific activity. For that purpose, we now report the preparation of 3 H-labeled chlorisondamine (4,5,6,7-tetrachloro-2-[ 3 H]methyl-2-(2-trimethylammoniumethyl)-isoindolinium diiodide) of high specific activity (94 Ci/mmol). The compound was synthesized by quarternization of 4,5,6,7-tetrachloro-2-(2-trimethylammoniumethylisoindolinium iodide with pertritiated methyl iodide in dimethylformamide at high temperature in a sealed vessel.


πŸ“œ SIMILAR VOLUMES


The synthesis of betaxolol labelled with
✍ John Allen; AndrΓ© Tizot πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 French βš– 204 KB

## Department of Chemistry Labelled Compounds and Metabolite Synthesis Group 31, avenue Paul Vaillant-Couturier 92220 BAGNEUX (FRANCE) SmOuRY The synthesis of betaxolol, a new 8-blocking agent. labelled with tritium in high specific activity ('19 Ci/mmol) is described. The tritium was incorporated

Super high specific activity tritium lab
✍ Leyi Gong; Howard Parnes πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 French βš– 406 KB πŸ‘ 2 views

We describe herein the synthesis of polybromodiphenylacetic acid (&), a fragment common to the tritiation substrates (a) and (JJ) of the sodium channel blocker, PD-85639 (1) and the angiotensin II inhibitor EXP-655 (2) respectively. Preparation of (a) and (11) followed by reductive debromonation wit

A convenient method for the specific tri
✍ Anders Arfwidsson; GΓΆran Hallhagen; Kurt-JΓΌrgen Hoffmann πŸ“‚ Article πŸ“… 1980 πŸ› John Wiley and Sons 🌐 French βš– 461 KB

## Abstract The specific tritium labelling of beta‐adrenoceptor antagonists of the general structure ArOCH~2~CH(OH)CH~2~NHR is described. The tritium label is introduced in the 2‐position in the aminohydroxypropoxy side‐chain starting from ArOCH, an intermediate in the synthesis of the unlabelled c

The preparation and stability of DL-Ξ±-to
✍ E. A. Evans; R. F. Phillips πŸ“‚ Article πŸ“… 1969 πŸ› John Wiley and Sons 🌐 French βš– 389 KB

Hydrogen-tritium exchange labelling methods proved to be unsatisfactory for the preparation of tritiated DL-a-tocopherol at high specific activity. The preparation of a-tocopherol specijcally labelled in the 5-methyl hydrogen positions is described : the method permits specific activities in the cur

Synthesis of high specific activity trit
✍ Ernest L. Siew; Yvette Habraken; David B. Ludlum πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 French βš– 286 KB

A small-scale synthesis of high specific activity, N-(2-chloro-2-[3H]-ethyl)-N'-cyclohexyl-N-nitrosourea ([3H]-CCNU) has been accomplished from tritium-labelled ethanolamine. The product is pure by TLC and HPLC analysis and has been used successfully to modify DNA. The overall yield on radioactivity